consumption compared to standard care , but participants experienced attendance challenges. People in need of assistance may not be able to attend in-person counseling sessions due to mobility limitations, lack of adequate transportation, living in areas where in-person sessions are not available, or difficulty traveling to in-person sessions (i.e., due to work, childcare; Marhefka et al., 2013 ), yet may benefit from an interactive, online, groupbased format. eHealth smoking cessation options for PLWH may mitigate attendance challenges (Ledgerwood & Yskes, 2016) .
Asynchronous Web-based app and text messaging programs have been tested, but evidence is limited on video-conferencing interventions (group-and individual-based) for both the general smoker population and for PLWH smokers. One telehealth program (Carlson et al., 2012) connected participant groups from remote sites to a group-based in-person program, but the participants did not access the program from their homes, nor did they navigate the technology on their own (i.e., each site had a facilitator who managed the site's technology). Still, the study suggested that video-conferencing groups (VGs) might be a viable option for smoking cessation. VGs offer a structured and supportive environment, components that may be key to effective interventions (Lustria et al., 2009) . To date, no study has assessed smoking cessation via VGs for PLWH.
Our study aimed to: (a) test acceptability of a facilitator-led, PLWH VG tobacco cessation program accessed individually; and (b) assess factors impacting adoption of a PLWH VG tobacco cessation program.
Methods
We present findings of two pilot studies that investigated VG delivery of Positively Smoke Free (PSF-VG), a video-group-based tobacco cessation program for PLWH . These studies were reviewed and approved by the Institutional Review Board at the University of South Florida. Participants met virtually using their own computers or tablets and a commercial video-conferencing platform. Inclusion criteria were that participants had to: (a) be a PLWH, (b) be an active smoker interested in cessation, and (c) have access to a computer with an Internet connection. Exclusion criteria were: (a) mentally or physically unable to complete intervention sessions, or (b) have unstable or inconsistent Internet access. Two trained facilitators (both tobacco cessation specialists; one a former smoker and a PLWH) delivered eight sessions over 6 weeks. The sessions, based on Social Cognitive Theory (Bandura, 1989) , focused on identifying triggers, determining alternative habits, introducing stress management techniques, and recognizing environmental and lifestyle cues.
In Study 1 (1 cohort, N 5 9), participants completed surveys at baseline, midway through program completion, and at 90 days postintervention paired with biochemical verification of tobacco use/ nonuse. Increased funding was available for Study 2 (2 cohorts, N 5 12), allowing additional assessments. Participants completed surveys at baseline, program completion, 90 days postintervention, and 180 days postintervention; biochemical verification was conducted at baseline and 90 days postintervention. Seven-day point prevalence abstinence (7ppa), was measured by asking participants, Have you smoked cigarettes (even a puff) in the last 7 days, including today? Oral swab test kits used to measure a tobacco metabolite (cotinine) were sent to participants, self-administered over individual video-conference for staff observation, and mailed to a laboratory. Quantitative analyses were conducted (SPSS v22; IBM, Armonk, NY 2013) using data from baseline and 90 days postintervention, as these time points could be compared across groups. Postintervention focus groups and session notes were analyzed thematically (Guest et al., 2012) , guided by Diffusion of Innovations theory (Rogers, 2003) .
Results
At baseline, all participants (N 5 21) had smoked in the previous 7 days. At 3-month follow-up, 3 participants (14%) reported 7ppa; one additional participant reported not smoking in the previous 7 days but smoked one puff at a party; biomarker tests confirmed all 4 (19%) participants had cotinine levels inconsistent with smoking (see Table 1 ).
PSF-VG impacted several smoking habits. After PSF-VG, participants delayed their first cigarette (p 5 .001). At baseline, 6 (29%) participants smoked their first cigarette within 5 minutes post waking, 13 (57%) within 6-30 minutes after waking, and 2 (10%) 31-60 minutes post waking. At 3 months post participation, of the 12 still smoking, no participants smoked 5 or fewer minutes post waking, 8 (38%) smoked 6-30 minutes post waking, 2 (10%) smoked within 31-60 minutes, and 2 (10%) smoked more than 60 minutes post waking (data not available for 5 participants). Moreover, participants reduced their smoking frequency. At baseline, 18 (86%) smoked daily; at 3-month follow-up, only 10 (63%) of 16 respondents smoked daily (p 5 .219). Although not statistically significant (p 5 .366), participants reduced the number of cigarettes they smoked each day. At baseline, 8 (38%) smoked 10 or fewer cigarettes/ day, 8 (38%) smoked 11-20 cigarettes, and 5 (24%) smoked 21-30 cigarettes. Of the 12 participants who smoked at 3-month follow-up, 8 (38%) smoked 10 or fewer cigarettes/day and 4 (19%) smoked 11-20 cigarettes/day.
During sessions and postprogram focus groups, participants expressed limited concerns over the risk associated with accessing VGs at home, such as fear that they ''might be talking to this person, but who's in the room with them?'' (i.e., another person could be in the room with group members and limit privacy). For many, these concerns were alleviated by group members using a headset, or trust developed between group members over time. Program acceptance was high, and data suggested promise for future adoption of such programs.
Diffusion of Innovations contracts are useful in guiding our understanding of participants' perceptions of PSF-VG (Rogers, 2003;  Table 2 ). Participants reported low program complexity, even among those with low technology literacy (e.g., ''for somebody who's not tech savvy, it's tech friendly and it wasn't difficult''). A positive impact on social interactions was described. Despite initial reservations, participants formed a cohesive group and looked forward to group sessions. The relative advantage of participating via VGs was noted. Many participants said they would not have participated in an in-person smoking cessation group due to past negative experiences (e.g., ''Sometimes with in-person groups it can become heated or confrontational''), concerns about in-person group settings (e.g., ''I have a lot of social anxiety, so I don't do well with groups . This, however, there's a comfort behind this, you know?''), or barriers to attending groups outside of their homes (e.g., '' [with PSF-VG] I didn't have to go anywhere''). The Note. 7ppa 5 7-day point prevalence abstinence. a. Mean (standard deviation). b. One participant self-reported having one puff of his partner's cigarette and thus did not meet the abstinence criteria. The level of cotinine in his system did not reach the level needed for a positive cotinine test, resulting in a discordance between self-report and biochemical confirmation. c. Data available only for study 2 (n 5 12); that is, 3/12 self-reported cessation at 180 days; 4/12 self-reported cessation at 270 days. possibility of connecting from home and the high trialability and reversibility (e.g., ''We're all on videoconference and I can just turn the camera off and walk away, and you're never gonna see me again'') made them willing to join. In addition, participants felt PSF-VG was compatible with their needs, as it addressed challenges they faced (i.e., both smoking and HIV-related concerns), all group members and one facilitator were PLWH, and both facilitators were former smokers (e.g., ''They came from a totally different approach than someone that has not walked in my shoes. You know, even down to the HIV.''). However, the program length was incompatible with their needs (i.e., participants stated additional sessions were needed after program completion). This resulted in participants suggesting at least one ''follow-up session, say, 3 months out, and retouch with people, and see [if] anybody fell off the wagon. Are they still experiencing the issues they had before? Did they correct them?'' Participants made substantial progress but wanted additional support. Despite any barriers to adoption and participation, all participants would recommend the program to other PLWH who wanted to quit smoking.
Discussion
VGs present an exciting opportunity to increase intervention reach, particularly for those who cannot or will not participate in in-person groups. Guided by Diffusion of Innovations theory (Rogers, 2003) , our study highlights the acceptability and potential for future adoption of VG cessation programs for PLWH. Findings build on work demonstrating the acceptability, feasibility, and effectiveness of VG delivery of a secondary prevention program for PLWH (Green et al., 2015; Marhefka et al., 2014; Marhefka et al., 2013) . Participants liked accessing PSF-VG from home and viewed participation as low risk because they could easily disconnect if they did not like the program. Quit rates (19% biochemical abstinence) were greater than other tobacco cessation programs for PLWH (Pool et al., 2016) . Together, our findings suggest that PSF-VG, if proven effective, could be an important option within a compendium of choices (Bekele et al, 2017; Ledgerwood & Yskes, 2016) to help PLWH smokers quit.
In addition to providing proof of concept, our findings suggest that booster sessions (Alharbi et al., 2016) might be important for smoking cessation interventions with PLWH. After eight intensive group-based sessions, participants wanted additional sessions to help them meet and maintain their goals. Booster sessions have been shown to be effective in reducing biomarker levels when provided in a structured format that enhanced initial intervention content and involved problem-solving strategies for behavioral changes (Goldberg et al., 2015) .
Marketing for VG-based tobacco cessation should highlight ease of use, low-risk investment (i.e., trialability and reversibility), and facilitators' smoking experiences. Potential participants, especially those with prior negative experiences with in-person groups, might be comforted knowing they could press a button to disconnect from the VG. Participants unable to access in-person groups might respond to the relative advantages and convenience of VGs (Green et al., 2015) . Those intimidated by technology or eHealth could be persuaded by the low complexity of the technology.
Study limitations include the small sample size and lack of a control condition. Pilot groups were only in English. The follow-up period was short (90 days for all participants; 180 self-report, followup for Study 2 participants only). Yet findings highlighted factors important to individual adoption decisions regarding VG tobacco cessation and could be used to further develop VG-based tobacco cessation programs for PLWH, a high-priority group (Engels et al., 2006; Helleberg et al., 2013; Hile et al., 2016; Mdodo et al., 2015; Siddiqi & Mdege, 2016) . Additionally, VGs may be a promising option for more general audiences.
Because some participants decreased their tobacco use but did not quit, and participants requested additional sessions (regardless of cessation status), booster sessions should be tested in a definitive PSF-VG trial. Hispanics/Latinos accounted for 24% of new HIV diagnoses in 2014 (Centers for Disease Control and Prevention, 2016); thus, PSF-VG should be tested with Spanish-speakers to expand potential reach. Long-term follow-up assessments are needed to determine effect maintenance over time (Hughes et al., 2003; Pool et. al., 2016) . Regarding implementation, findings related to marketing VGs should also be tested. More broadly, research should explore the potential role of VGs in expanding access to smoking cessation for non-PLWH. State quit-line services could employ a tobacco cessation specialist to deliver VG programs from a centralized location at various times of the week or day to expand service costs effectively (Marhefka et al., 2013) . Ultimately, VGs could help to achieve national smoking cessation objectives as well as reduce smoking-related morbidity and mortality.
Conclusion
VGs have the potential to expand access to care for people who may otherwise have limited opportunities to attend in-person group-based programs. Our mixed-method pilot study demonstrated the potential feasibility and acceptability of PSF-VG, an HIV-tailored smoking cessation program delivered via VGs accessed on participants' own devices. Results suggest that high trialability and reversibility enhance the potential of PSF-VG to help reduce smoking among PLWH, literally by ''meeting them where they are''-especially if enhanced with booster sessions.
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